FI850193A0 - Terapeutiska lhrh analoger. - Google Patents

Terapeutiska lhrh analoger.

Info

Publication number
FI850193A0
FI850193A0 FI850193A FI850193A FI850193A0 FI 850193 A0 FI850193 A0 FI 850193A0 FI 850193 A FI850193 A FI 850193A FI 850193 A FI850193 A FI 850193A FI 850193 A0 FI850193 A0 FI 850193A0
Authority
FI
Finland
Prior art keywords
analoger
lhrh
therapeutic
therapeutic lhrh
lhrh analoger
Prior art date
Application number
FI850193A
Other languages
English (en)
Other versions
FI850193L (fi
Inventor
David H Coy
Jacques-Pierre Moreau
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Publication of FI850193A0 publication Critical patent/FI850193A0/fi
Publication of FI850193L publication Critical patent/FI850193L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI850193A 1984-06-18 1985-01-16 Terapeutiska lhrh analoger. FI850193L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,673 US4632979A (en) 1984-06-18 1984-06-18 Therapeutic LHRH analogs

Publications (2)

Publication Number Publication Date
FI850193A0 true FI850193A0 (fi) 1985-01-16
FI850193L FI850193L (fi) 1985-12-19

Family

ID=24491153

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850193A FI850193L (fi) 1984-06-18 1985-01-16 Terapeutiska lhrh analoger.

Country Status (12)

Country Link
US (1) US4632979A (fi)
EP (1) EP0171477A3 (fi)
JP (1) JPS617297A (fi)
AU (1) AU4376485A (fi)
CA (1) CA1257950A (fi)
DK (1) DK615084A (fi)
ES (1) ES8702438A1 (fi)
FI (1) FI850193L (fi)
NO (1) NO852439L (fi)
NZ (1) NZ212454A (fi)
PT (1) PT80658B (fi)
ZA (1) ZA854590B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
NZ213759A (en) * 1984-10-19 1989-01-27 Genentech Inc Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
ZA862570B (en) * 1985-04-09 1986-12-30 Univ Tulane Therapeutic decapeptides
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
EP0328090A3 (en) * 1988-02-10 1990-08-16 Abbott Laboratories Lhrh analogs
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
JP2672677B2 (ja) * 1989-02-09 1997-11-05 タツプ・フアーマシユーテイカルズ・インコーポレイテツド Ｌｈｒｈ同族体
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
HU208158B (en) * 1990-02-20 1993-08-30 Syntex Inc Process for the synthesis of 1h-rh analogs by temporary protection
JPH06510046A (ja) * 1991-08-26 1994-11-10 アボツト・ラボラトリーズ 治療薬の舌下または頬投与のための組成物及び方法
CN102112145B (zh) 2008-06-12 2014-07-30 辛它可辛有限公司 神经内分泌病的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50142563A (fi) * 1974-04-26 1975-11-17
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4018726A (en) * 1975-06-12 1977-04-19 Andrew Victor Schally [D-Phe6 ]-LH-RH and intermediates therefor
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
US4071622A (en) * 1976-02-11 1978-01-31 Abbott Laboratories Treatment of a mammary or DMBA inducible tumor
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
FR2450109B1 (fr) * 1977-11-08 1986-03-28 Roussel Uclaf Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4244946A (en) * 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
US4253997A (en) * 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
US4321260A (en) * 1980-05-22 1982-03-23 Ayerst, Mckenna & Harrison Inc. Method of using gonadorelin for the treatment of benign prostatic hyperplasia
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists

Also Published As

Publication number Publication date
PT80658A (en) 1985-07-01
US4632979A (en) 1986-12-30
EP0171477A2 (en) 1986-02-19
JPS617297A (ja) 1986-01-13
DK615084A (da) 1985-12-19
EP0171477A3 (en) 1987-10-14
CA1257950A (en) 1989-07-25
PT80658B (en) 1986-12-09
ES544316A0 (es) 1987-01-01
ES8702438A1 (es) 1987-01-01
AU4376485A (en) 1986-01-02
NZ212454A (en) 1988-09-29
NO852439L (no) 1985-12-19
FI850193L (fi) 1985-12-19
DK615084D0 (da) 1984-12-20
ZA854590B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
FI883757A (fi) Terapeutiska nukleosider.
FI862094A0 (fi) Bornerande terapeutisk komposition.
ATE120194T1 (de) Therapeutische nuleoside.
FI903656A0 (fi) Terapeutiska kinuklidinfoereningar.
DE3873127D1 (de) Therapeutische praeparate.
FI881651A (fi) Terapeutiska nukleosider.
DE3689354D1 (de) Herzschrittmacher.
FI850946A0 (fi) Medicinska plaoster.
DE3689347D1 (de) Herzschrittmacher.
FI875098A (fi) Transdermalt terapeutiskt system.
DE3581730D1 (de) Menschlicher tumornekrosisfaktor.
DE3669105D1 (de) Therapeutische zusammensetzung.
IT8522058A0 (it) Perfezionamenti riguardanti la terapia con ciclosporine.
FI850193A0 (fi) Terapeutiska lhrh analoger.
FI853249L (fi) Cdna-kloner foer human erytropoietin.
FI875039A0 (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
FI865069A0 (fi) Terapeutiskt system.
FI893897A0 (fi) Terapeutiska nukleosider.
DE3650261D1 (de) Herzschrittmacher.
FI843266A0 (fi) Terapeutiska aemnen.
FI852658A0 (fi) Farmaceutiska aemnen.
FI881216A0 (fi) Terapeutiska nukleosider.
FI894321A0 (fi) Terapeutiska aemnen.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THE ADMINISTRATORS OF THE TULANE